Ordentlich Peter (CIK 0001594274)

Latest company ownership

SNDX - Syndax Pharmaceuticals Inc

Role: Chief Scientific Officer

Shares held

7,572

Last filed at

Feb 17, 2023

Confidence Score

50.0

2025Q4

Confidence Score History

2017Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Feb 15, 2023	Feb 17, 2023	Syndax Pharmaceuticals Inc	Chief Scientific Officer	Sell	7.5	-25,000	-100.00%	✓	$646.1K
Jan 31, 2023	Feb 3, 2023	Syndax Pharmaceuticals Inc	Chief Scientific Officer	Sell	52.5	-	0.00%	✗	$766.5
Dec 1, 2022	Dec 2, 2022	Syndax Pharmaceuticals Inc	Chief Scientific Officer	Sell	7.5	-25,000	-96.92%	✓	$626K
Jul 29, 2022	Aug 26, 2022	Syndax Pharmaceuticals Inc	Chief Scientific Officer	Sell	7.5	-24,735	-96.89%	✓	$622.2K
Jan 31, 2022	Feb 3, 2022	Syndax Pharmaceuticals Inc	Chief Scientific Officer	Sell	52.5	-	0.00%	✗	$6K
Nov 23, 2020	Nov 25, 2020	Syndax Pharmaceuticals Inc	Chief Scientific Officer	Sell	20.0	-29,972	-100.00%	✗	$694.1K
Apr 3, 2018	Apr 3, 2018	Syndax Pharmaceuticals Inc	Chief Scientific Officer	Sell	10.0	-7,500	-100.00%	✓	$112.5K
May 17, 2017	May 19, 2017	Syndax Pharmaceuticals Inc	Chief Scientific Officer	Sell	10.0	-5,000	-100.00%	✓	$75K